Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-016516
Filing Date
2025-04-03
Accepted
2025-04-03 16:27:28
Documents
1
Period of Report
2025-04-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1743712039.html 4  
1 FORM 4 wk-form4_1743712039.xml 4 4825
  Complete submission text file 0001628280-25-016516.txt   6370
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Khattar Jack A. (Reporting) CIK: 0001539937 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 25809921